All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • [F-18]FlorastaminPhase 32 trials

    FutureChem · High Risk Prostate Carcinoma

  • 1.0% IP-001IP-001Phase 32 trials

    Immunophotonics, Inc. · Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer

  • 177Lu-edotreotide PRRT177Lu-DOTATOC, 177Lu-EdoPhase 32 trials

    ITM Solucin GmbH · Neuroendocrine Tumors

  • 177Lu-NYM032Phase 32 trials

    Norroy Bioscience Co., LTD · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

  • 6-Thio-2'-Deoxyguanosine6-thio-dG, THIOPhase 32 trials

    Maia Biotechnology · Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small -Cell Lung

  • 7MW3711Phase 32 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Lung Squamous Cell Carcinoma

  • A166Phase 32 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Her 2 Positive Breast Cancer, HER2-positive Breast Cancer

  • AAA817[225Ac]Ac-PSMA-617Phase 32 trials

    Novartis · Prostate Cancer

  • ABP 206Phase 32 trials

    Amgen · Melanoma

  • ABP 234Phase 32 trials

    Amgen · Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

  • anzutresgene autoleucelIMA203 Product, IMA203 product- flat dosePhase 32 trials

    Immatics US, Inc. · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • ARDTPhase 32 trials

    Novartis · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms

  • ARPI: EnzalutamideARPI abirateronePhase 32 trials

    Novartis · Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer

  • ASKC202Phase 32 trials

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive

  • AST-001Phase 32 trials

    Ascentawits Pharmaceuticals, Ltd · Solid Tumor, Pancreatic Cancer, Autism Spectrum Disorder

  • ATG-022Phase 32 trials

    Antengene Biologics Limited · Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

  • AU-011Bel-sarPhase 32 trials

    Aura Biosciences · Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma

  • BAT1308Recombinant humanized anti-PD-1 monoclonal antibodyPhase 32 trials

    Bio-Thera Solutions · Cervical Cancer, Advanced Solid Tumors

  • BCD-217Phase 32 trials

    Biocad · Melanoma Stage III, Melanoma (Skin), Melanoma

  • BefotertinibPhase 32 trials

    Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, EGFR Sensitive Mutation, Adjuvant Therapy

  • BL-8040Phase 32 trials

    BioLineRx, Ltd. · Multiple Myeloma, Pancreatic Adenocarcinoma

  • BL-M14D1Phase 32 trials

    SystImmune Inc. · Small Cell Lung Cancer Extensive Stage, Small-cell Lung Cancer, Small Cell Carcinoma

  • BrenetafuspIMC-F106CPhase 32 trials

    Immunocore Ltd · Select Advanced Solid Tumors, Advanced Melanoma

  • CDK4Phase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Advanced ER+/HER2- Breast Cancer, Breast Cancer

  • CF102NamodenosonPhase 32 trials

    Can-Fite BioPharma · Pancreatic Adenocarcinoma, Pancreatic Cancer, Hepatocellular Carcinoma

  • CMP 001VidutolimodPhase 32 trials

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • CobolimabPhase 32 trials

    GSK · Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma

  • Copper Cu 64 PSMA I&TPhase 32 trials

    Curium US LLC · Prostate Cancer, Prostate Adenocarcinoma, Biochemical Recurrence of Malignant Neoplasm of Prostate

  • CRB-701Phase 32 trials

    Corbus Pharmaceuticals Inc. · Solid Tumor, Adult, Oropharyngeal Carcinoma (OPC)

  • CTXPhase 32 trials

    Ascentage Pharma Group Inc. · CLL/SLL, Breast Cancer

  • CTX-009Phase 32 trials

    Compass Therapeutics · Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer

  • DN022150Phase 32 trials

    Jiangxi Kvvit Pharmaceutical Co., Ltd. · Pancreatic Cancer, Pancreatic Carcinoma

  • EG-007Phase 32 trials

    Evergreen Therapeutics, Inc. · Advanced Endometrial Cancer

  • EmactuzumabPhase 32 trials

    Roche (Genentech) · Cancer, TGCT

  • EnlituoPhase 32 trials

    Taizhou Mabtech Pharmaceutical Co.,Ltd · Colorectal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)

  • EU-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • EzabenlimabBI 754091Phase 32 trials

    Boehringer Ingelheim · Advanced Cancer, Neoplasm Metastasis, Advanced Tumors

  • FG-M108M108Phase 32 trials

    FutureGen Biopharmaceutical (Beijing) Co., Ltd · Claudin 18.2, Solid Tumor Malignancies, Pancreatic Cancer

  • FicerafuspPhase 32 trials

    Bicara Therapeutics · Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma

  • GLS-010Phase 32 trials

    Guangzhou Gloria Biosciences Co., Ltd. · Solid Tumor, Persistent, Recurrent, or Metastatic Cervical Cancer

  • HLX87Phase 32 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • HMPL-306Phase 32 trials

    Hutchmed · Acute Myeloid Leukemia, Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

  • HMPL-453Phase 32 trials

    Hutchmed · Advanced Intrahepatic Cholangiocarcinoma, Solid Tumor, Adult, Solid Tumor

  • IBI310Phase 32 trials

    Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma

  • Inactive controlQLS-111 vehiclePhase 32 trials

    Can-Fite BioPharma · Hepatocellular Carcinoma, Cirrhosis, Open-angle Glaucoma (OAG)

  • INCA33890Phase 32 trials

    Incyte · CRC (Colorectal Cancer)

  • IparomlimabPhase 32 trials

    Qilu Pharmaceutical Co., Ltd. · Small-cell Lung Cancer, Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

  • JAB-3312Phase 32 trials

    Allist Pharmaceuticals, Inc. · KRAS P.G12C, Non-small Cell Lung Cancer, Colorectal Cancer

  • JK-1201IPhase 32 trials

    JenKem Technology Co., Ltd. · Glioblastoma Multiforme (GBM), Small Cell Lung Cancer

  • JMT103NarlumosbartPhase 32 trials

    Shanghai JMT-Bio Inc. · Giant Cell Tumor of Bone, Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors

NewerPage 5 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.